More importantly, in the primary cells of 51 BC‐transformed patients with CML, the expression patterns of Cobll1, PACSIN2, and SH3BP1 were significantly associated with blast cell percentage. The gene discussed is PACSIN2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.